Gerhard Ransmayr Selected Research

Gerhard Ransmayr Research Topics

Disease

6	Parkinson Disease (Parkinson's Disease) 01/2023 - 08/2007
6	Dementia (Dementias) 10/2021 - 01/2012
3	Epilepsy (Aura) 03/2021 - 02/2004
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2003
2	Relapsing-Remitting Multiple Sclerosis 01/2020 - 12/2014
2	Cognitive Dysfunction 01/2020 - 01/2019
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2023
1	Multiple System Atrophy 01/2023
1	Nervous System Diseases (Neurological Disorders) 03/2022
1	Glioma (Gliomas) 03/2021
1	Seizures (Absence Seizure) 03/2021
1	Infections 03/2021
1	Multiple Sclerosis 01/2020
1	Juvenile Myoclonic Epilepsy 01/2020
1	Atrophy 01/2020
1	Prodromal Symptoms 01/2019
1	Drug-Related Side Effects and Adverse Reactions 01/2017
1	Pain (Aches) 01/2017
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Orthostatic Hypotension (Postural Hypotension) 01/2014
1	Psychotic Disorders (Schizoaffective Disorder) 07/2012
1	Dyskinesias (Dyskinesia) 07/2010
1	Tremor (Tremors) 04/2009
1	Migraine with Aura (Familial Hemiplegic Migraine) 02/2004
1	Migraine Disorders (Migraine) 02/2004
1	Schizophrenia (Dementia Praecox) 03/2003

Drug/Important Bio-Agent (IBA)

4	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2019
2	Leucine (L-Leucine)FDA Link 03/2021 - 08/2007
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 03/2003
2	Amantadine (Aman)FDA LinkGeneric 07/2012 - 07/2010
1	SynucleinsIBA 01/2023
1	AntigensIBA 03/2021
1	AntibodiesIBA 03/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2021
1	Surface Antigens (Surface Antigen)IBA 03/2021
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2020
1	Natalizumab (Tysabri)FDA Link 01/2020
1	nitazoxanide (NTZ)FDA Link 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	rotigotine FDA Link 01/2017
1	AD 20 (AD-20)IBA 01/2017
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2015
1	Rivastigmine (Exelon)FDA LinkGeneric 12/2015
1	Donepezil (Aricept)FDA LinkGeneric 12/2015
1	Memantine (Namenda)FDA Link 12/2015
1	Riluzole FDA LinkGeneric 01/2015
1	Intravenous Immunoglobulins (IVIG)FDA Link 12/2014
1	hydroxide ionIBA 01/2014
1	Phosphotransferases (Kinase)IBA 08/2007
1	Anticonvulsants (Antiepileptic Drugs)IBA 02/2004
1	Topiramate (Topamax)FDA LinkGeneric 02/2004
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 03/2003
1	Adenosine (Adenocard)FDA LinkGeneric 03/2003
1	Amyloid (Amyloid Fibrils)IBA 01/2003
1	Cytochrome P450 Family 46 (CYP46)IBA 01/2003
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2003
1	CholesterolIBA 01/2003
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2003

Therapy/Procedure

3	Activities of Daily Living (ADL) 10/2021 - 01/2012
1	Examination Tables 01/2023
1	Long-Term Care 03/2021
1	Cutaneous Administration 01/2017
1	Transdermal Patch 01/2017
1	Self Medication 07/2012
1	Therapeutics 04/2009